Xanomeline 

Xanomeline
IUPAC name 3-(4-hexoxy-1,2,5-thiadiazol-3-yl)-1-methyl-5,6-dihydro-2H-pyridine
Identifiers
CAS number 131986-45-3
PubChem 60809
MeSH xanomeline
SMILES
 
Properties
Molecular formula C14H23N3OS
Molar mass 281.42 g mol−1
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)
Infobox references

Xanomeline is a muscarinic agonist selective for the M1 subtype.1 It has recently been studied in Europe for the cognitive and negative symptoms of Schizophrenia, and there were robust associated improvements in verbal learning and short-term memory. 2

References

  1. ^ Farde L, Suhara T, Halldin C, et al (1996). "PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man". Dementia 7 (4): 187–95. PMID 8835881. 
  2. ^ Am J Psychiatry. 2008 Aug;165(8):1033-9. Epub 2008 Jul 1. Links Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia.Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dubé S, Mallinckrodt C, Bymaster FP, McKinzie DL, Felder CC.
Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
v • d • e
Parasympathomimetics / cholinergic agonists / acetylcholinesterase inhibitors (N06DA, N07AA)
Direct
(at receptor)
Indirect/AIs
(in synapse)